|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL.: (2006.01) |
A61K 9/08 A61K 8/30 A61K 35/66 A61K 38/00 A61K 38/16 A61K 38/43 A61K 47/02 A61K 47/12 A61K 47/42 A61P 1/00 A61P 11/00 A61P 13/00 A61P 15/00 A61P 21/00 A61P 25/00 A61P 27/00 A61P 43/00 A61Q 19/00 C07K 14/195 |
| (11) | Number of the document | 4959 |
| (13) | Kind of document | B |
| (21) | Application number | 2001 041 |
| (22) | Date of filing the application | 2001-04-10 |
| (41) | Date of publication of the application | 2002-06-25 |
| (45) | Date of publication of patent | 2002-10-25 |
| (86) | Number | PCT/US99/20912 |
| Date | 1999-09-09 |
| (87) | Number | WO 00/15245 |
| Date | 2000-03-23 |
| (30) | Number | Date | Country code |
| 60/099, 870 | 1998-09-11 | US |
| (71) |
ELAN PHARMACEUTICALS, Inc.,
800 Gateway Boulevard, South San Francisco, CA 94080,
US
|
| (72) |
Elizabeth MOYER, US
Pamela HIRTZER, US |
| (73) |
Solstice Neurosciences, Inc.,
40 General Warren Blvd. Suite 160, Malvern, PA 19355,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | STABLE LIQUID FORMULATIONS OF BOTULINUM TOXIN |
| Payment date | Validity (years) | Amount | |
| 2010-08-18 | 12 | 1000.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2011-09-09 |